Literature DB >> 11226641

Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.

P Haussermann1, W Kuhn, H Przuntek, T Muller.   

Abstract

Dysfunction of the blood-cerebrospinal fluid barrier (BCB) has been implicated in the pathogenesis of Parkinson's disease (PD) and other neurodegenerative disorders. Therefore, we assayed serum and cerebrospinal fluid (CSF) from 30 parkinsonian patients and 30 controls for concentrations of albumin and IgG. The CSF/serum ratio for albumin (AQ), IgG (GQ), IgG-index as well as determination of oligoclonal bands were used to evaluate BCB function and to quantify humoral immune response within the central nervous system (CNS). Levels of AQ, GQ and IgG-index did not significantly differ in both groups. We found no dysfunction of the blood-CSF barrier or signs of local synthesis of IgG in the central nervous system of parkinsonian patients. Our data do not support the hypothesis of a dysfunctional BCB that contributes to pathophysiological mechanisms underlying PD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226641     DOI: 10.1016/s0304-3940(01)01574-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspects.

Authors:  Peter Riederer; Thomas Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-03-22       Impact factor: 3.575

2.  TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice.

Authors:  Chaohui Zhao; Zaodung Ling; Mary B Newman; Ankush Bhatia; Paul M Carvey
Journal:  Neurobiol Dis       Date:  2007-01-17       Impact factor: 5.996

3.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

Authors:  Vanessa Brochard; Béhazine Combadière; Annick Prigent; Yasmina Laouar; Aline Perrin; Virginie Beray-Berthat; Olivia Bonduelle; Daniel Alvarez-Fischer; Jacques Callebert; Jean-Marie Launay; Charles Duyckaerts; Richard A Flavell; Etienne C Hirsch; Stéphane Hunot
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

Review 4.  The role of inflammation in sporadic and familial Parkinson's disease.

Authors:  Michela Deleidi; Thomas Gasser
Journal:  Cell Mol Life Sci       Date:  2013-05-12       Impact factor: 9.261

5.  Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease.

Authors:  Valerio Pisani; Alessandro Stefani; Mariangela Pierantozzi; Silvia Natoli; Paolo Stanzione; Diego Franciotta; Antonio Pisani
Journal:  J Neuroinflammation       Date:  2012-08-08       Impact factor: 8.322

6.  Evaluation of the objective posturo-locomotor-manual method in patients with parkinsonian syndromes.

Authors:  Theresa Zackrisson; Filip Bergquist; Björn Holmberg; Bo Johnels; Thorleif Thorlin
Journal:  Front Neurol       Date:  2013-07-19       Impact factor: 4.003

Review 7.  Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.

Authors:  Ricardo Cabezas; Marcos Avila; Janneth Gonzalez; Ramon Santos El-Bachá; Eliana Báez; Luis Miguel García-Segura; Juan Camilo Jurado Coronel; Francisco Capani; Gloria Patricia Cardona-Gomez; George E Barreto
Journal:  Front Cell Neurosci       Date:  2014-08-04       Impact factor: 5.505

Review 8.  Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

Authors:  Karin D van Dijk; Charlotte E Teunissen; Benjamin Drukarch; Connie R Jimenez; Henk J Groenewegen; Henk W Berendse; Wilma D J van de Berg
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 9.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

Review 10.  Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Authors:  Vanesa Sanchez-Guajardo; Christopher J Barnum; Malú G Tansey; Marina Romero-Ramos
Journal:  ASN Neuro       Date:  2013-04-30       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.